Your browser doesn't support javascript.
Decoupling of omicron variant infections and severe COVID-19.
Madhi, Shabir A; Ihekweazu, Chikwe; Rees, Helen; Pollard, Andrew J.
  • Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Parktown 2193, South Africa. Electronic address: shabir.madhi@wits.ac.za.
  • Ihekweazu C; World Health Organization, Hub for Pandemic and Epidemic Intelligence, Berlin, Germany.
  • Rees H; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Parktown 2193, South Africa.
  • Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
Lancet ; 399(10329): 1047-1048, 2022 03 12.
Article in English | MEDLINE | ID: covidwho-1692766
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Vaccine Efficacy Type of study: Prognostic study Topics: Vaccines / Variants Limits: Humans Language: English Journal: Lancet Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Vaccine Efficacy Type of study: Prognostic study Topics: Vaccines / Variants Limits: Humans Language: English Journal: Lancet Year: 2022 Document Type: Article